Skip to main content
. 2023 Feb 8;53(3):337–352. doi: 10.1111/cea.14276

TABLE 2.

Estimates of within centre, absolute percentage point change in eczema outcomes per decade

Model Strata Number of centres in strata Outcome
Current eczema symptoms Severe current eczema symptoms Lifetime eczema
Estimate of within centre, absolute percentage point change in eczema outcomes per decade (95% CI) Interaction test & AIC Estimate of within centre, absolute percentage point change in eczema outcomes per decade (95% CI) Interaction test & AIC Estimate of within centre, absolute percentage point change in eczema outcomes per decade (95% CI) Interaction test & AIC
Stratified by age group Age 13–14 253 0.98 (0.04, 1.92)

Age:

p = .53

AIC = 2144

0.26 (0.06, 0.46)

Age:

p = .70

AIC = 768

2.71 (1.10, 4.32)

Age:

p = .15

AIC = 2743

Age 6–7 157 1.21 (0.18, 2.24) 0.23 (0.02, 0.45) 3.91 (2.07, 5.75)
Random effects Slope SD: 2.40 (1.68, 3.43) Slope SD: 0.58 (0.40, 0.83) Slope SD: 2.87 (1.68, 4.93)
Stratified by age group and income group (test for addition of income) Age 13–14 Low income 47 −1.48 (−3.56, 0.60)

Income (3‐way):

p < .0001

AIC = 2118

−0.02 (−0.49, 0.45)

Income (3‐way):

p = .10

AIC = 771

0.03 (−3.36, 3.41)

Income (3‐way):

p < .0001

AIC = 2677

Low‐middle income 40 2.32 (0.40, 4.25) 0.71 (0.29, 1.14) 1.44 (−1.95, 4.82)
Upper‐middle income 62 1.66 (−0.06, 3.37) 0.23 (−0.15, 0.61) 3.93 (0.96, 6.89)
High income 104 0.45 (−0.99, 1.88) 0.12 (−0.20, 0.44) 2.29 (−0.14, 4.72)
Age 6–7 Low income 29 −1.06 (−3.30, 1.18) −0.03 (−0.52, 0.47) 0.02 (−3.74, 3.78)
Low‐middle income 15 0.35 (−2.11, 2.80) 0.38 (−0.14, 0.91) 3.35 (−1.20, 7.91)
Upper‐middle income 43 1.63 (−0.22, 3.47) 0.10 (−0.30, 0.51) 5.50 (2.22, 8.78)
High income 70 2.41 (0.87, 3.95) 0.32 (−0.02, 0.66) 7.46 (4.77, 10.14)
Random effects Slope SD: 2.18 (1.45, 3.26) Slope SD: 0.54 (0.36, 0.80) Slope SD: 2.83 (1.58, 5.06)
Stratified by age group and grouped region (test for addition of region) Age 13–14 Africa and Eastern Mediterranean 34 2.83 (0.67, 5.00)

Region (3‐way):

p = .0001

AIC = 2129

0.82 (0.38, 1.27)

Region (3‐way):

p < .0001 AIC = 741

2.93 (−0.66, 6.53)

Region (3‐way):

p < .0001

AIC = 2711

Americas 50 0.37 (−1.56, 2.31) 0.14 (−0.26, 0.55) 2.61 (−0.42, 5.63)
Europe 100 0.01 (−1.61, 1.63) 0.01 (−0.33, 0.34) 2.12 (−0.58, 4.82)
South‐East Asia and Western Pacific 69 1.29 (−0.64, 3.22) 0.31 (−0.10, 0.72) 1.72 (−1.14, 4.57)
Age 6–7 Africa and Eastern Mediterranean 10 1.59 (−1.50, 4.67) 0.75 (0.14, 1.35) 4.57 (−1.37, 10.51)
Americas 29 −0.01 (−2.10, 2.08) −0.01 (−0.44, 0.42) 3.59 (0.14, 7.04)
Europe 64 1.21 (−0.59, 3.00) −0.01 (−0.37, 0.36) 8.45 (5.26, 11.65)
South‐East Asia and Western Pacific 54 1.77 (−0.20, 3.73) 0.36 (−0.05, 0.78) 1.58 (−1.36, 4.52)
Random effects Slope SD: 2.51 (1.82, 3.47) Slope SD: 0.57 (0.41, 0.80) Slope SD: 2.68 (1.26, 5.68)

Note: Changes come from mixed effect linear regression models of eczema outcomes on three‐way interactions between time, age group, and either world income group or geographic region, with random country and centre slopes and intercepts.

Abbreviations: AIC, Akaike Information Criterion; CI, confidence interval; SD, standard deviation.